Madrigal Pharmaceuticals
MDGL
MDGL
120 hedge funds and large institutions have $954M invested in Madrigal Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 43 increasing their positions, 34 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 111 → 120 (+9)
5.39% more ownership
Funds ownership: 62.49% → 67.88% (+5.4%)
92% less call options, than puts
Call options by funds: $2.31M | Put options by funds: $28M
Holders
120
Holding in Top 10
2
Calls
$2.31M
Puts
$28M
Top Buyers
| 1 | +$12M | |
| 2 | +$11.2M | |
| 3 | +$10.5M | |
| 4 |
HI
HBK Investments
Dallas,
Texas
|
+$6.83M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$6.4M |
Top Sellers
| 1 | -$8.67M | |
| 2 | -$4M | |
| 3 | -$2.63M | |
| 4 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$2.59M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2.16M |